Send to

Choose Destination
Arch Pathol Lab Med. 1990 Feb;114(2):160-3.

Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.

Author information

Department of Pathology, University of Vermont, College of Medicine, Burlington 05405.


Fifty patients with typical infiltrating ductal adenocarcinoma of the breast were studied for amplification of the c-erb B-2 (neu/HER-2) oncogene within the tumor DNA. Amplification, ranging from 4 to greater than 50 copies per cell, was observed in 17 (34%) of the samples. The presence of c-erb B-2 gene amplification was not significantly correlated with patient survival, metastases, recurrence, or overall histologic grade. However, amplification was significantly associated with increased mitotic activity. Also, amplification of c-erb B-2 showed a significantly negative association with both progesterone and estrogen receptor presence. Progesterone receptor presence correlated significantly with survival.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center